Man With Duchenne Muscular Dystrophy Celebrates 50th Birthday After Grim Prognosis as a Child
source: pixabay.com

Man With Duchenne Muscular Dystrophy Celebrates 50th Birthday After Grim Prognosis as a Child

  Andrew Taylor celebrated his 50th birthday this year. This is a big year for anyone, but especially for Taylor, who was told he would not make it to the…

Continue Reading Man With Duchenne Muscular Dystrophy Celebrates 50th Birthday After Grim Prognosis as a Child
First Treatment for X-Linked Hypophosphatemia Gains Approval in Canada
Taokinesis / Pixabay

First Treatment for X-Linked Hypophosphatemia Gains Approval in Canada

According to a story from pm360online.com, the biopharmaceutical company Ultragenyx Pharmaceutical Inc., in collaboration with Kyowa Hakko Kirin Co. Ltd, and Kyowa Kirin International PLC, recently announced that injectable burosumab…

Continue Reading First Treatment for X-Linked Hypophosphatemia Gains Approval in Canada
Homocystinuria is More Common Than We Thought, It’s Just Not Detected Well in NBS
https://pixabay.com/en/baby-care-child-cute-hand-face-20339/

Homocystinuria is More Common Than We Thought, It’s Just Not Detected Well in NBS

Most patients diagnosed with Homocystinuria (HCU), a rare metabolic disorder, don't receive their diagnosis until later in life. Scientists were at a loss for why patients with phenylketonuria (PKU), a similar…

Continue Reading Homocystinuria is More Common Than We Thought, It’s Just Not Detected Well in NBS
Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia
crystal710 / Pixabay

Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia

According to a story from PR Newswire, the 60th Annual Meeting of the American Society of Hematology has been generating a lot of press lately as many groundbreaking studies, research,…

Continue Reading Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia
Early Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic Leukemia Released
jarmoluk / Pixabay

Early Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic Leukemia Released

According to a story from BioPortfolio, the global biopharmaceutical company Celgene Corporation recently announced the release of early data from the dose-escalation portion of a Phase 1/2 clinical trial of lisocabtagene…

Continue Reading Early Dose-Escalation Data for Potential Treatment for Chronic Lymphocytic Leukemia Released
International Experts Met with Goal to Improve Care for Chronic Myelomonocytic Leukemia Patients
https://pixabay.com/en/earth-planet-space-satellite-1913747/

International Experts Met with Goal to Improve Care for Chronic Myelomonocytic Leukemia Patients

Chronic myelomonocytic leukemia, or CMML, is a rare condition. However, it has similarities to myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). That being said, it still a unique diagnosis, and…

Continue Reading International Experts Met with Goal to Improve Care for Chronic Myelomonocytic Leukemia Patients
Potential New Treatment for Huntington’s Disease Granted Orphan Drug Designation
Source: Pixabay.com

Potential New Treatment for Huntington’s Disease Granted Orphan Drug Designation

Huntington's Disease is a neurodegenerative condition caused by a genetic mutation. It results in progressive decline of motor skills. It also affects cognitive function. Patients experience decline for 15-20 years…

Continue Reading Potential New Treatment for Huntington’s Disease Granted Orphan Drug Designation
A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients
Source: Pixabay.com

A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients

Mantle cell lymphoma is caused by a genetic mutation which  produces cancerous white blood cells. Of course, these are the cells which fight infection in a normal body. Therefore in…

Continue Reading A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients

Experimental Gene Therapy for Fanconi Anemia Earns Fast Track and Regenerative Medicine Advanced Therapy Designation

According to a story from BioPortfolio, the gene therapy company Rocket Pharmaceuticals has recently announced that the company's investigational gene therapy RP-L102 has earned both Fast Track and Regenerative Medicine…

Continue Reading Experimental Gene Therapy for Fanconi Anemia Earns Fast Track and Regenerative Medicine Advanced Therapy Designation